Related references
Note: Only part of the references are listed.The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
Barrett W. Newsome et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins
Thomas G. M. Schmidt et al.
NATURE PROTOCOLS (2007)
Design of humanized antibodies: From anti-Tac to Zenapax
N Tsurushita et al.
METHODS (2005)
Stability improvement of antibodies for extracellular and intracellular applications:: CDR grafting to stable frameworks and structure-based framework engineering
S Ewert et al.
METHODS (2004)
Humanization of a chicken anti-IL-12 monoclonal antibody
N Tsurushita et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach
M Schlapschy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
An engineered IN-1Fab fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity
M Fiedler et al.
PROTEIN ENGINEERING (2002)
Improving the efficacy of antibody-based cancer therapies
P Carter
NATURE REVIEWS CANCER (2001)
Targeting properties of an anti-CD16/anti-CD30 bispecific: antibody in an in vivo system
C Renner et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2001)
Kabat Database and its applications: future directions
G Johnson et al.
NUCLEIC ACIDS RESEARCH (2001)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin
S Schlehuber et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors
A Wörn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
